Product Information

DONEPEZIL HCL 23 MG TABLET is a generic product labeled by Edenbridge Pharmaceuticals LLC, priced at $0.7291 per EA under NDC 42799095402. Its NADAC has been published 133 times since Feb 7, 2024.

FDA first approved this application on Feb 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Donepezil hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DONEPEZIL HCL 23 MG TABLET has been published 133 times since Feb 7, 2024, and over the history we have for it it has risen 13.3%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.